Cargando…
Intima-media thickness evolution after treatment with infliximab in patients with rheumatoid arthritis
BACKGROUND: Atherosclerosis is a well known progressive disease that recognizes risk factors such as diabetes, hypertension, smoking, dyslipidemia, and inflammation. Mechanisms underlying atherosclerotic processes during inflammation are not completely understood, but cytokines are also involved, in...
Autores principales: | Di Micco, Pierpaolo, Ferrazzi, Paola, Librè, Luca, Mendolicchio, Loredana, Quaglia, Ilaria, De Marco, Monica, Colombo, Anna, Bacci, Monica, Rota, Lidia Luciana, Lodigiani, Corrado |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2840561/ https://www.ncbi.nlm.nih.gov/pubmed/20360897 |
Ejemplares similares
-
Differences in the INR evaluation of two different thromboplastins in patients with positivity to lupus anticoagulant in ongoing oral anticoagulation
por: Ferrazzi, Paola, et al.
Publicado: (2010) -
Is there a relationship between factor V Leiden and type 2 diabetes?
por: Lodigiani, Corrado, et al.
Publicado: (2009) -
Homocysteine, MTHFR C677T gene polymorphism, folic acid and vitamin B 12 in patients with retinal vein occlusion
por: Ferrazzi, Paola, et al.
Publicado: (2005) -
SV-IV Peptide1–16 reduces coagulant power in normal Factor V and Factor V Leiden
por: Di Micco, Biagio, et al.
Publicado: (2007) -
Inflammation, carotid intima-media thickness and atherosclerosis in rheumatoid arthritis
por: Veldhuijzen van Zanten, Jet JCS, et al.
Publicado: (2008)